Intraperitoneal treatment for advanced ovarian cancer, the Dutch experience. What did we learn?
CONCLUSION: In daily practice, 54% of patients with advanced OC could complete all scheduled cycles of iv/ ip chemotherapy with acceptable morbidity and toxicity, leading to outcomes comparable with the results of published trials on iv/ip chemotherapy.PMID:33380532
Source: The Netherlands Journal of Medicine - Category: General Medicine Authors: M J A Rietveld J van der Velden A M Westermann W J van Driel G S Sonke P O Witteveen F K Ploos van Amstel L F A G Massuger P B Ottevanger Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | General Medicine | Learning | Netherlands Health | Ovarian Cancer | Ovaries | Study | Toxicology | Universities & Medical Training | Women